Global Neurofibromatoses Type II Therapecutics Market Professional Survey Report 2017

January 2018 | 104 pages | ID: GED109328B6EN
QYResearch

Abstracts

This report studies Neurofibromatoses Type II Therapecutics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Arno Therapeutics Inc
• AstraZeneca Plc
• Beta Pharma Inc
• Lixte Biotechnology Holdings Inc
• Plex Pharmaceuticals Inc
• Recursion Pharmaceuticals Inc

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• AR-42
• FRAX-597
• Icotinib Hydrochloride
• LB-201
• LB-205
• Others

By Application, the market can be split into

• Clinic
• Hospital
• Home Care

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Neurofibromatoses Type II Therapecutics Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF NEUROFIBROMATOSES TYPE II THERAPECUTICS

1.1 Definition and Specifications of Neurofibromatoses Type II Therapecutics
  1.1.1 Definition of Neurofibromatoses Type II Therapecutics
  1.1.2 Specifications of Neurofibromatoses Type II Therapecutics
1.2 Classification of Neurofibromatoses Type II Therapecutics
  1.2.1 AR-42
  1.2.2 FRAX-597
  1.2.3 Icotinib Hydrochloride
  1.2.4 LB-201
  1.2.5 LB-205
  1.2.6 Others
1.3 Applications of Neurofibromatoses Type II Therapecutics
  1.3.1 Clinic
  1.3.2 Hospital
  1.3.3 Home Care
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF NEUROFIBROMATOSES TYPE II THERAPECUTICS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Neurofibromatoses Type II Therapecutics
2.3 Manufacturing Process Analysis of Neurofibromatoses Type II Therapecutics
2.4 Industry Chain Structure of Neurofibromatoses Type II Therapecutics

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF NEUROFIBROMATOSES TYPE II THERAPECUTICS

3.1 Capacity and Commercial Production Date of Global Neurofibromatoses Type II Therapecutics Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Neurofibromatoses Type II Therapecutics Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Neurofibromatoses Type II Therapecutics Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Neurofibromatoses Type II Therapecutics Major Manufacturers in 2016

4 GLOBAL NEUROFIBROMATOSES TYPE II THERAPECUTICS OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Neurofibromatoses Type II Therapecutics Capacity and Growth Rate Analysis
  4.2.2 2016 Neurofibromatoses Type II Therapecutics Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Neurofibromatoses Type II Therapecutics Sales and Growth Rate Analysis
  4.3.2 2016 Neurofibromatoses Type II Therapecutics Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Neurofibromatoses Type II Therapecutics Sales Price
  4.4.2 2016 Neurofibromatoses Type II Therapecutics Sales Price Analysis (Company Segment)

5 NEUROFIBROMATOSES TYPE II THERAPECUTICS REGIONAL MARKET ANALYSIS

5.1 North America Neurofibromatoses Type II Therapecutics Market Analysis
  5.1.1 North America Neurofibromatoses Type II Therapecutics Market Overview
  5.1.2 North America 2012-2017E Neurofibromatoses Type II Therapecutics Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Neurofibromatoses Type II Therapecutics Sales Price Analysis
  5.1.4 North America 2016 Neurofibromatoses Type II Therapecutics Market Share Analysis
5.2 China Neurofibromatoses Type II Therapecutics Market Analysis
  5.2.1 China Neurofibromatoses Type II Therapecutics Market Overview
  5.2.2 China 2012-2017E Neurofibromatoses Type II Therapecutics Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Neurofibromatoses Type II Therapecutics Sales Price Analysis
  5.2.4 China 2016 Neurofibromatoses Type II Therapecutics Market Share Analysis
5.3 Europe Neurofibromatoses Type II Therapecutics Market Analysis
  5.3.1 Europe Neurofibromatoses Type II Therapecutics Market Overview
  5.3.2 Europe 2012-2017E Neurofibromatoses Type II Therapecutics Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Neurofibromatoses Type II Therapecutics Sales Price Analysis
  5.3.4 Europe 2016 Neurofibromatoses Type II Therapecutics Market Share Analysis
5.4 Southeast Asia Neurofibromatoses Type II Therapecutics Market Analysis
  5.4.1 Southeast Asia Neurofibromatoses Type II Therapecutics Market Overview
  5.4.2 Southeast Asia 2012-2017E Neurofibromatoses Type II Therapecutics Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Neurofibromatoses Type II Therapecutics Sales Price Analysis
  5.4.4 Southeast Asia 2016 Neurofibromatoses Type II Therapecutics Market Share Analysis
5.5 Japan Neurofibromatoses Type II Therapecutics Market Analysis
  5.5.1 Japan Neurofibromatoses Type II Therapecutics Market Overview
  5.5.2 Japan 2012-2017E Neurofibromatoses Type II Therapecutics Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Neurofibromatoses Type II Therapecutics Sales Price Analysis
  5.5.4 Japan 2016 Neurofibromatoses Type II Therapecutics Market Share Analysis
5.6 India Neurofibromatoses Type II Therapecutics Market Analysis
  5.6.1 India Neurofibromatoses Type II Therapecutics Market Overview
  5.6.2 India 2012-2017E Neurofibromatoses Type II Therapecutics Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Neurofibromatoses Type II Therapecutics Sales Price Analysis
  5.6.4 India 2016 Neurofibromatoses Type II Therapecutics Market Share Analysis

6 GLOBAL 2012-2017E NEUROFIBROMATOSES TYPE II THERAPECUTICS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Neurofibromatoses Type II Therapecutics Sales by Type
6.2 Different Types of Neurofibromatoses Type II Therapecutics Product Interview Price Analysis
6.3 Different Types of Neurofibromatoses Type II Therapecutics Product Driving Factors Analysis
  6.3.1 AR-42 of Neurofibromatoses Type II Therapecutics Growth Driving Factor Analysis
  6.3.2 FRAX-597 of Neurofibromatoses Type II Therapecutics Growth Driving Factor Analysis
  6.3.3 Icotinib Hydrochloride of Neurofibromatoses Type II Therapecutics Growth Driving Factor Analysis
  6.3.4 LB-201 of Neurofibromatoses Type II Therapecutics Growth Driving Factor Analysis
  6.3.5 LB-205 of Neurofibromatoses Type II Therapecutics Growth Driving Factor Analysis
  6.3.6 Others of Neurofibromatoses Type II Therapecutics Growth Driving Factor Analysis

7 GLOBAL 2012-2017E NEUROFIBROMATOSES TYPE II THERAPECUTICS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Neurofibromatoses Type II Therapecutics Consumption by Application
7.2 Different Application of Neurofibromatoses Type II Therapecutics Product Interview Price Analysis
7.3 Different Application of Neurofibromatoses Type II Therapecutics Product Driving Factors Analysis
  7.3.1 Clinic of Neurofibromatoses Type II Therapecutics Growth Driving Factor Analysis
  7.3.2 Hospital of Neurofibromatoses Type II Therapecutics Growth Driving Factor Analysis
  7.3.3 Home Care of Neurofibromatoses Type II Therapecutics Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF NEUROFIBROMATOSES TYPE II THERAPECUTICS

8.1 Arno Therapeutics Inc
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Arno Therapeutics Inc 2016 Neurofibromatoses Type II Therapecutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Arno Therapeutics Inc 2016 Neurofibromatoses Type II Therapecutics Business Region Distribution Analysis
8.2 AstraZeneca Plc
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 AstraZeneca Plc 2016 Neurofibromatoses Type II Therapecutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 AstraZeneca Plc 2016 Neurofibromatoses Type II Therapecutics Business Region Distribution Analysis
8.3 Beta Pharma Inc
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Beta Pharma Inc 2016 Neurofibromatoses Type II Therapecutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Beta Pharma Inc 2016 Neurofibromatoses Type II Therapecutics Business Region Distribution Analysis
8.4 Lixte Biotechnology Holdings Inc
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Lixte Biotechnology Holdings Inc 2016 Neurofibromatoses Type II Therapecutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Lixte Biotechnology Holdings Inc 2016 Neurofibromatoses Type II Therapecutics Business Region Distribution Analysis
8.5 Plex Pharmaceuticals Inc
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Plex Pharmaceuticals Inc 2016 Neurofibromatoses Type II Therapecutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Plex Pharmaceuticals Inc 2016 Neurofibromatoses Type II Therapecutics Business Region Distribution Analysis
8.6 Recursion Pharmaceuticals Inc
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Recursion Pharmaceuticals Inc 2016 Neurofibromatoses Type II Therapecutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Recursion Pharmaceuticals Inc 2016 Neurofibromatoses Type II Therapecutics Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF NEUROFIBROMATOSES TYPE II THERAPECUTICS MARKET

9.1 Global Neurofibromatoses Type II Therapecutics Market Trend Analysis
  9.1.1 Global 2017-2022 Neurofibromatoses Type II Therapecutics Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Neurofibromatoses Type II Therapecutics Sales Price Forecast
9.2 Neurofibromatoses Type II Therapecutics Regional Market Trend
  9.2.1 North America 2017-2022 Neurofibromatoses Type II Therapecutics Consumption Forecast
  9.2.2 China 2017-2022 Neurofibromatoses Type II Therapecutics Consumption Forecast
  9.2.3 Europe 2017-2022 Neurofibromatoses Type II Therapecutics Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Neurofibromatoses Type II Therapecutics Consumption Forecast
  9.2.5 Japan 2017-2022 Neurofibromatoses Type II Therapecutics Consumption Forecast
  9.2.6 India 2017-2022 Neurofibromatoses Type II Therapecutics Consumption Forecast
9.3 Neurofibromatoses Type II Therapecutics Market Trend (Product Type)
9.4 Neurofibromatoses Type II Therapecutics Market Trend (Application)

10 NEUROFIBROMATOSES TYPE II THERAPECUTICS MARKETING TYPE ANALYSIS

10.1 Neurofibromatoses Type II Therapecutics Regional Marketing Type Analysis
10.2 Neurofibromatoses Type II Therapecutics International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Neurofibromatoses Type II Therapecutics by Region
10.4 Neurofibromatoses Type II Therapecutics Supply Chain Analysis

11 CONSUMERS ANALYSIS OF NEUROFIBROMATOSES TYPE II THERAPECUTICS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL NEUROFIBROMATOSES TYPE II THERAPECUTICS MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Neurofibromatoses Type II Therapecutics
Table Product Specifications of Neurofibromatoses Type II Therapecutics
Table Classification of Neurofibromatoses Type II Therapecutics
Figure Global Production Market Share of Neurofibromatoses Type II Therapecutics by Type in 2016
Figure AR-42 Picture
Table Major Manufacturers of AR-42
Figure FRAX-597 Picture
Table Major Manufacturers of FRAX-597
Figure Icotinib Hydrochloride Picture
Table Major Manufacturers of Icotinib Hydrochloride
Figure LB-201 Picture
Table Major Manufacturers of LB-201
Figure LB-205 Picture
Table Major Manufacturers of LB-205
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Neurofibromatoses Type II Therapecutics
Figure Global Consumption Volume Market Share of Neurofibromatoses Type II Therapecutics by Application in 2016
Figure Clinic Examples
Table Major Consumers in Clinic
Figure Hospital Examples
Table Major Consumers in Hospital
Figure Home Care Examples
Table Major Consumers in Home Care
Figure Market Share of Neurofibromatoses Type II Therapecutics by Regions
Figure North America Neurofibromatoses Type II Therapecutics Market Size (Million USD) (2012-2022)
Figure China Neurofibromatoses Type II Therapecutics Market Size (Million USD) (2012-2022)
Figure Europe Neurofibromatoses Type II Therapecutics Market Size (Million USD) (2012-2022)
Figure Southeast Asia Neurofibromatoses Type II Therapecutics Market Size (Million USD) (2012-2022)
Figure Japan Neurofibromatoses Type II Therapecutics Market Size (Million USD) (2012-2022)
Figure India Neurofibromatoses Type II Therapecutics Market Size (Million USD) (2012-2022)
Table Neurofibromatoses Type II Therapecutics Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Neurofibromatoses Type II Therapecutics in 2016
Figure Manufacturing Process Analysis of Neurofibromatoses Type II Therapecutics
Figure Industry Chain Structure of Neurofibromatoses Type II Therapecutics
Table Capacity and Commercial Production Date of Global Neurofibromatoses Type II Therapecutics Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Neurofibromatoses Type II Therapecutics Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Neurofibromatoses Type II Therapecutics Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Neurofibromatoses Type II Therapecutics Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Neurofibromatoses Type II Therapecutics 2012-2017
Figure Global 2012-2017E Neurofibromatoses Type II Therapecutics Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Neurofibromatoses Type II Therapecutics Market Size (Value) and Growth Rate
Table 2012-2017E Global Neurofibromatoses Type II Therapecutics Capacity and Growth Rate
Table 2016 Global Neurofibromatoses Type II Therapecutics Capacity (K Pcs) List (Company Segment)
Table 2012-2017E Global Neurofibromatoses Type II Therapecutics Sales (K Pcs) and Growth Rate
Table 2016 Global Neurofibromatoses Type II Therapecutics Sales (K Pcs) List (Company Segment)
Table 2012-2017E Global Neurofibromatoses Type II Therapecutics Sales Price (USD/Pcs)
Table 2016 Global Neurofibromatoses Type II Therapecutics Sales Price (USD/Pcs) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Pcs) of Neurofibromatoses Type II Therapecutics 2012-2017E
Figure North America 2012-2017E Neurofibromatoses Type II Therapecutics Sales Price (USD/Pcs)
Figure North America 2016 Neurofibromatoses Type II Therapecutics Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Pcs) of Neurofibromatoses Type II Therapecutics 2012-2017E
Figure China 2012-2017E Neurofibromatoses Type II Therapecutics Sales Price (USD/Pcs)
Figure China 2016 Neurofibromatoses Type II Therapecutics Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Pcs) of Neurofibromatoses Type II Therapecutics 2012-2017E
Figure Europe 2012-2017E Neurofibromatoses Type II Therapecutics Sales Price (USD/Pcs)
Figure Europe 2016 Neurofibromatoses Type II Therapecutics Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of Neurofibromatoses Type II Therapecutics 2012-2017E
Figure Southeast Asia 2012-2017E Neurofibromatoses Type II Therapecutics Sales Price (USD/Pcs)
Figure Southeast Asia 2016 Neurofibromatoses Type II Therapecutics Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Pcs) of Neurofibromatoses Type II Therapecutics 2012-2017E
Figure Japan 2012-2017E Neurofibromatoses Type II Therapecutics Sales Price (USD/Pcs)
Figure Japan 2016 Neurofibromatoses Type II Therapecutics Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Pcs) of Neurofibromatoses Type II Therapecutics 2012-2017E
Figure India 2012-2017E Neurofibromatoses Type II Therapecutics Sales Price (USD/Pcs)
Figure India 2016 Neurofibromatoses Type II Therapecutics Sales Market Share
Table Global 2012-2017E Neurofibromatoses Type II Therapecutics Sales (K Pcs) by Type
Table Different Types Neurofibromatoses Type II Therapecutics Product Interview Price
Table Global 2012-2017E Neurofibromatoses Type II Therapecutics Sales (K Pcs) by Application
Table Different Application Neurofibromatoses Type II Therapecutics Product Interview Price
Table Arno Therapeutics Inc Information List
Table Product A Overview
Table Product B Overview
Table 2016 Arno Therapeutics Inc Neurofibromatoses Type II Therapecutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Arno Therapeutics Inc Neurofibromatoses Type II Therapecutics Business Region Distribution
Table AstraZeneca Plc Information List
Table Product A Overview
Table Product B Overview
Table 2016 AstraZeneca Plc Neurofibromatoses Type II Therapecutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 AstraZeneca Plc Neurofibromatoses Type II Therapecutics Business Region Distribution
Table Beta Pharma Inc Information List
Table Product A Overview
Table Product B Overview
Table 2015 Beta Pharma Inc Neurofibromatoses Type II Therapecutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Beta Pharma Inc Neurofibromatoses Type II Therapecutics Business Region Distribution
Table Lixte Biotechnology Holdings Inc Information List
Table Product A Overview
Table Product B Overview
Table 2016 Lixte Biotechnology Holdings Inc Neurofibromatoses Type II Therapecutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Lixte Biotechnology Holdings Inc Neurofibromatoses Type II Therapecutics Business Region Distribution
Table Plex Pharmaceuticals Inc Information List
Table Product A Overview
Table Product B Overview
Table 2016 Plex Pharmaceuticals Inc Neurofibromatoses Type II Therapecutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Plex Pharmaceuticals Inc Neurofibromatoses Type II Therapecutics Business Region Distribution
Table Recursion Pharmaceuticals Inc Information List
Table Product A Overview
Table Product B Overview
Table 2016 Recursion Pharmaceuticals Inc Neurofibromatoses Type II Therapecutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Recursion Pharmaceuticals Inc Neurofibromatoses Type II Therapecutics Business Region Distribution
Figure Global 2017-2022 Neurofibromatoses Type II Therapecutics Market Size (K Pcs) and Growth Rate Forecast
Figure Global 2017-2022 Neurofibromatoses Type II Therapecutics Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Neurofibromatoses Type II Therapecutics Sales Price (USD/Pcs) Forecast
Figure North America 2017-2022 Neurofibromatoses Type II Therapecutics Consumption Volume (K Pcs) and Growth Rate Forecast
Figure China 2017-2022 Neurofibromatoses Type II Therapecutics Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Europe 2017-2022 Neurofibromatoses Type II Therapecutics Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Neurofibromatoses Type II Therapecutics Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Japan 2017-2022 Neurofibromatoses Type II Therapecutics Consumption Volume (K Pcs) and Growth Rate Forecast
Figure India 2017-2022 Neurofibromatoses Type II Therapecutics Consumption Volume (K Pcs) and Growth Rate Forecast
Table Global Sales Volume (K Pcs) of Neurofibromatoses Type II Therapecutics by Type 2017-2022
Table Global Consumption Volume (K Pcs) of Neurofibromatoses Type II Therapecutics by Application 2017-2022
Table Traders or Distributors with Contact Information of Neurofibromatoses Type II Therapecutics by Region